
Join to view full profile
3199 Highland AveCincinnati, OH 45219
Phone+1 513-558-7651
Fax+1 513-558-7651
Dr. Dluzynski is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Pennsylvania State University College of MedicineClass of 2025
Publications & Presentations
PubMed
- 1 citationsDose-dependent impact of tixagevimab-cilgavimab as primary prevention against SARS-CoV-2 in immunocompromised individuals.Daniela Dluzynski, Paddy Ssentongo, Cory M Hale, Shareef K Shaheen, Natella Maglakelidze
Scientific Reports. 2025-05-21 - Tolerability and outcomes with rollout of tixagevimab-cilgavimab in patients with common variable immunodeficiency.Daniela Dluzynski, Taha Al-Shaikhly, Catharine I Paules, Maria Paula Henao
The Journal of Allergy and Clinical Immunology. Global. 2024-08-01 - 6 citationsUse of Integrative, Complementary, and Alternative Medicine in Children with Epilepsy: A Global Scoping Review.Zahra Zhu, Daniela Dluzynski, Nouran Hammad, Deepika Pugalenthi, Sarah A Walser
Children. 2023-04-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









